You're never on the same dose twice. Here's why GLP-1s feel so inconsistent.

Dr. Ian Ellis lost 30 lb on semaglutide, then ran the numbers and realized why week one felt amazing and week five made him sick, even though his dose never changed.

Zepbound Dosing: Your Doctor Probably Didn't Tell You About This Issue

Ian Ellis knew he had a problem. At 40 lb overweight and 35 percent body fat, fresh out of residency in 2016, the ER doctor who had once maintained 6 to 8 percent body fat was snoring like a freight train and could not walk upstairs without getting winded. He had been a certified personal trainer, a nutritionist, someone who at 14 stood in front of a mirror and vowed never to lose the battle everyone around him was losing.

For years he won by sheer obsession. Three hours on the treadmill. Two workouts a day, six days a week. Counting every calorie in MyFitnessPal. Running a marathon the day after Thanksgiving to burn the 2,600 calories he had logged. He looked the part. Inside, it was toxic.

Medical school and residency stripped all that away. A hundred and twenty hour weeks. Cupcakes at the nurse's station. No time to compensate with exercise. He became what he most feared.

In late 2021, a colleague in the ER mentioned a new drug called Ozempic. Ellis had never heard of it. The colleague said it was magic, it took away your appetite, you just lost weight. Ellis said sign me up. He started 0.25 mg of semaglutide a week later.

I took my first three bites and I got halfway through the sandwich and I just didn't want to eat it anymore. I went, what the hell was that? Is this what it's like to feel satiated?On The Pen™ GLP-1 News

1. Week one felt like heaven. Week five he could not leave the bathroom.

The first week on 0.25 mg, Ellis made a ribeye sandwich. Normally he would have eaten one, maybe two, then another half, then gotten on the treadmill for three hours. This time he took three bites, got halfway through, and did not want to finish it. Not because he felt sick or overstuffed. He just did not have the desire. He wrapped it up, put it in the fridge, and thought: is this what satiety feels like?

The second week, after his second injection, he did not feel quite as good. A slight food aversion. A tinge of nausea when he ate. Still losing weight, still in a calorie deficit, but not that blissful first week.

Week three got worse. Nausea, diarrhea, low energy, not eating much at all. His gym performance suffered. Week five, after he increased to 0.5 mg as instructed, the wheels fell off. Intractable nausea, vomiting, diarrhea. He could not eat, could not function.

He had followed the protocol to the letter. Same dose for four weeks, then doubled. But his experience changed every single week, even when the dose did not.

Why this matters if you haven’t started yet: If your first week felt great and your third week felt terrible on the same dose, you are not crazy. The medication level in your body was climbing the entire time.

2. He lost 30 lb. Two pounds of muscle for every pound of fat.

Three months in, Ellis had lost 30 lb. The scale was moving. He was not fighting his appetite anymore, he was fighting different battles. Then he got on an InBody scanner, a body composition tool he had used for years and had data going back to his bodybuilding cuts.

The results horrified him. He had lost 30 lb at a ratio of two pounds of lean mass for every one pound of fat. His body fat percentage had barely changed. He was smaller, weaker, and did not have anywhere near the physique he had at that weight in the past.

He knew why. He had not eaten in three months. When he did eat, he was too sick to get protein in, so he ate simple carbs because they made his stomach feel better. He was not exercising with intensity to remind his muscles to hang around. He was getting overall poor nutrition.

The outcome was predictable. But it raised a question: can these medicines be used in a way where that is not the outcome?

Why this matters if you haven’t started yet: This is the outcome most people on standard dosing are heading toward if they are not tracking body composition and prioritizing protein and resistance training.

3. The half-life means you are never on the same dose twice.

Ellis went back to that first week. He felt great. If he could feel like that every day, that would be perfect. Week two he felt worse. Week five he got really sick. He took the same dose each week, but had a different experience. Why?

He cracked open pharmacology textbooks and talked to pharmacists. Semaglutide has a seven day half-life. If you inject 1 mg on day zero, a week later half of it is still in your body. When you take your second dose of 1 mg, you are not starting from zero. You now have 1.5 mg in you. That is a 50 percent increase in your level.

The third dose stacks. The fourth dose stacks. You have four different therapeutic levels of medicine in the first month, even at fixed dosing. By week five, when the standard protocol says to double your dose to 0.5 mg, you are at three times the medication level you were in week one.

Ellis realized: the standard dosing ladder was designed brilliantly for a clinical trial to assess efficacy at defined levels on a population. It was never designed to ask what is the right level for an individual person, and if you can find it, how do you stay there.

Most people that use GLP-1s are never actually on the same dose twice, despite the number that's on the pen. And that might be why so many people struggle with these medications and eventually give them up.On The Pen™ GLP-1 News

Why this matters if you haven’t started yet: The standard protocol escalates you through 20 weeks of dosing, and in that entire time you do not have the same medication experience on any two weeks.

4. There is a green zone. The ladder never lets you stay in it.

Every medication has a therapeutic window, a range where you get maximal benefit and minimal side effects. Go above it, you get more side effects without more benefit. Go below it, the drug does not work. Ibuprofen is an easy example. You need enough to bring your fever down, but not so much you tear up your stomach.

Everyone has an individual therapeutic window for a GLP-1. Their appetite is controlled. They still get hungry, but when they eat they feel full fast. They have good energy, no GI side effects, and they can move forward.

The problem is the standard dosing ladder inexorably steps people up and never gives them the chance to hold. It was designed to gradually move people to defined steady state levels for a study, not to find what works for you and stay there.

In a perverse turn of events, Ellis says, we applied a study protocol designed for the New England Journal of Medicine to individual patients, no matter how tall they are, how big, how old, their starting point. Everyone gets on the same escalator and we tell them to try to make it to the top.

Why this matters if you haven’t started yet: A lot of people do not need 15 mg of tirzepatide or 2.4 mg of semaglutide. Some do not need 5 mg. One of Ellis's patients lost 30 lb and never reached the 2.5 mg starting dose.

5. One patient got violently sick on a third of the starting dose.

Mary Alice came to Ellis wanting to lose 20 lb. She was 30 years old and warned him: I am really sensitive to medicine. I am scared of side effects. Ellis took the standard starting dose of tirzepatide, 2.5 mg, and cut it in thirds. He started her on less than 1 mg.

She got super sick. She did not leave the bathroom for a week.

What would the standard protocol say to do? Hold the dose there. But if they had held it, the next week her level would have been higher because of stacking. The pharmacokinetics do not change just because your dose is lower.

Ellis dropped her next dose to one unit in an insulin syringe, a tenth of the starting dose. Three months later she had lost her 30 lb. Her maintenance dose was about a third of the starting dose of tirzepatide. Had she gone to a typical doctor, she would have started on 2.5 mg, been sick as a dog, and either quit or had a miserable three months losing weight the wrong way.

Why this matters if you haven’t started yet: This is the population most at risk on standard dosing: people who are smaller, older, or highly sensitive to medication and need a fraction of the dose to reach their therapeutic window.

6. His clinic's patients lost more weight on half the medicine.

Ellis retired from the ER, opened his own clinic, and spent a year figuring out if precision dosing worked not just for him but for others. He did a retrospective on his first 112 patients dosed with his method: find your minimum effective level, dose to that level, and increase by small increments (average 2 percent) when you plateau, not by doubling.

They lost weight faster than the landmark trials. They lost at a rate of 1.1 to 1.3 times the trial results on a time-matched interval. But they used 50 percent of the medicine.

How is that possible? The standard dosing ladder, if you overdose, is malignant to muscle mass and dangerous to metabolism. You reach a plateau earlier if you are losing muscle and metabolism and not getting nutrition. The only solution the standard ladder has is to double your dose, which makes the problem worse.

The better solution: find the minimum effective level and do not go above that unless you have to. Allow your body to lose 1 to 2 lb a week in a sustainable way. Avoid side effects. If you have side effects, go down a little, because those side effects have a metabolic cost, a muscle mass cost, a nutrition cost.

Why this matters if you haven’t started yet: Forty to seventy percent of people quit GLP-1s, split about equally between side effects and cost. Those two are related. If you jack up your dose, you take more medicine, spend more money, and probably have worse side effects, potentially without any increase in the rate of weight loss.

7. One patient went from 310 lb to under 200 and got both knees replaced.

Pat May came to Ellis mid-sixties, 310 lb at five feet tall, BMI north of 50. She had severe osteoarthritis in both knees, was immobile, had multiple comorbidities, heart and kidney issues, and had just been hospitalized for kidney failure and sepsis. She was excluded from the trials. She was disqualified for bilateral knee replacement surgery because of her BMI. She was not qualified for bariatric surgery because of her comorbidities.

The standard dosing protocol would say: sorry, good luck. This person cannot tolerate side effects.

Ellis treated her based on level, not dose. A year later she had lost over 100 lb, was nearing 200 lb, had already gotten one knee replacement, and was on track for her second the following month.

Ellis says the elderly population, particularly those who do not exercise, do not have lean mass to spare but do have fat tissue to lose. It is a medical imperative to treat this population, but equally imperative to find a better way because they cannot take the risk of muscle loss and metabolic slowdown.

Why this matters if you haven’t started yet: If Medicare coverage opens up GLP-1s to older patients without better dosing protocols, Ellis warns, it could be a catastrophe in terms of sarcopenia, broken hips, and osteoporosis.

8. He built an app that calculates your level in real time.

Ellis spent a week with pharmacology textbooks, chat GPT, and pharmacists figuring out the equations. Can I calculate my level based on all my previous doses? Turns out you can. Can I calculate how much to take at any given time to get back to the level where I felt good? Yes.

He did it first in Google sheets for himself, then for his patients one at a time for a year. It worked, but it was not scalable. So he built an app.

The app calculates in real time how much medicine is in you right now (your current level, the green line) and what your target is (your ideal level, the purple line, called MyLevel). It splits the total dosing range into 50 steps. When you increase, you go up 2 percent in your experience, not 2 percent in your dose. Most people do not need an increase bigger than three steps. The app puts up a warning if you try to go higher.

Within the first few weeks, with supervision from a provider, you find your sweet spot. You put a pin in it. This is where I feel my best. Every dose you take, no matter whether it is early, late, two days before a trip, or two days after, the app calculates how much you need to take to get right back to where you felt good.

GLP-1s, when dosed with precision, can be like a thermostat dial for your appetite. You say, I want a little more control, I want a little more room, I have an event coming up I'd like to enjoy. Let your levels drop a little and catch up with precision later.On The Pen™ GLP-1 News

Why this matters if you haven’t started yet: This is not an app practicing medicine. All dosing decisions are supervised by a provider. The app just does the math and gives visibility to both patient and provider.

Ellis is not saying precision dosing is the only solution. Clinics are experimenting with microdosing, split dosing, other ways to match experience to dose. But he is not aware of anyone doing it with the degree of visibility and precision his method uses, because without technology you cannot see your level, and without seeing it you cannot calculate the dose to stay there.

The tool is available now for clinics and providers. Ellis is working on a large scale IRB trial to validate the method prospectively so other clinics can join. His goal is for this to become the standard of care, not just for GLP-1s but for any long acting medicine (he is already applying it to testosterone). His dream is simple: make it possible for anyone who wants precision dosing to have it, and to find that place of balance where you are not controlled by the medicine and you can live your life.

Notice what is not on his list of mistakes: the drug. Not the dose, not the brand, not the pen. Every problem he describes is the way the drug is dosed, which is also why every one of them is fixable before you take your next injection.

Questions people ask

Why does my GLP-1 feel different every week even though my dose is the same?

Semaglutide and tirzepatide have long half-lives (about seven days), so each weekly dose stacks on top of what is still in your body from the previous week. Even at a fixed dose, your medication level rises for the first four to five weeks until it reaches steady state, which is why week one can feel great and week five can make you sick.

How much GLP-1 medication do I really need to lose weight?

It varies widely by individual. Some people need a fraction of the 2.5 mg starting dose, others need the full 15 mg of tirzepatide. The key is finding your minimum effective level, the amount that controls your appetite without side effects, and staying there rather than automatically escalating every four weeks.

Can I lose weight on a GLP-1 without losing muscle?

Yes, but it requires precision dosing to avoid overdosing, which causes severe appetite suppression, inadequate protein intake, and muscle loss. Patients in Dr. Ellis's clinic using level-based dosing lost weight faster than the trials but used half the medicine, which allowed them to eat enough protein and maintain muscle mass.

OT
On The Pen™ GLP-1 News

Dr. Ian Ellis is a board-certified emergency physician and founder of VoaFit, a clinic specializing in precision GLP-1 dosing. He has a background as a certified personal trainer and nutritionist and spent years battling body composition issues before treating himself and over 100 patients with a method that calculates exact medication levels rather than fixed doses. 88,193 views on the original video.

Watch the original on YouTube →

Trending Topics